179 related articles for article (PubMed ID: 26730272)
1. Clinical value of gadoxetic acid-enhanced magnetic resonance imaging in surgery for hepatocellular carcinoma - with a special emphasis on early hepatocellular carcinoma.
Matsuda M
World J Hepatol; 2015 Dec; 7(30):2933-9. PubMed ID: 26730272
[TBL] [Abstract][Full Text] [Related]
2. Imaging features of subcentimeter hypointense nodules on gadoxetic acid-enhanced hepatobiliary phase MR imaging that progress to hypervascular hepatocellular carcinoma in patients with chronic liver disease.
Jang KM; Kim SH; Kim YK; Choi D
Acta Radiol; 2015 May; 56(5):526-35. PubMed ID: 24838304
[TBL] [Abstract][Full Text] [Related]
3. Presence of non-hypervascular hypointense nodules on Gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.
Inoue M; Ogasawara S; Chiba T; Ooka Y; Wakamatsu T; Kobayashi K; Suzuki E; Tawada A; Yokosuka O
J Gastroenterol Hepatol; 2017 Apr; 32(4):908-915. PubMed ID: 27787908
[TBL] [Abstract][Full Text] [Related]
4. Non-Hypervascular Hypointense Hepatic Nodules during the Hepatobiliary Phase of Gadolinium-Ethoxybenzyl-Diethylenetriamine Pentaacetic Acid-Enhanced MRI as a Risk Factor of Intrahepatic Distant Recurrence after Radiofrequency Ablation of Hepatocellular Carcinoma.
Iwamoto T; Imai Y; Igura T; Kogita S; Sawai Y; Fukuda K; Yamaguchi Y; Matsumoto Y; Nakahara M; Morimoto O; Ohashi H; Fujita N; Kudo M; Takehara T
Dig Dis; 2017; 35(6):574-582. PubMed ID: 29040990
[TBL] [Abstract][Full Text] [Related]
5. Recent Advances in the Imaging Diagnosis of Hepatocellular Carcinoma: Value of Gadoxetic Acid-Enhanced MRI.
Joo I; Lee JM
Liver Cancer; 2016 Feb; 5(1):67-87. PubMed ID: 26989660
[TBL] [Abstract][Full Text] [Related]
6. Non-hypervascular hypointense nodules on Gd-EOB-DTPA-enhanced MRI as a predictor of outcomes for early-stage HCC.
Toyoda H; Kumada T; Tada T; Sone Y; Maeda A; Kaneoka Y
Hepatol Int; 2015 Jan; 9(1):84-92. PubMed ID: 25788383
[TBL] [Abstract][Full Text] [Related]
7. Assessment of clinical and magnetic resonance imaging features of de novo hypervascular hepatocellular carcinoma using gadoxetic acid-enhanced magnetic resonance imaging.
Tamada T; Korenaga M; Yamamoto A; Higaki A; Kanki A; Nishina S; Hino K; Ito K
Hepatol Res; 2017 Mar; 47(3):E152-E160. PubMed ID: 27161283
[TBL] [Abstract][Full Text] [Related]
8. Focal lesions in the cirrhotic liver: their pivotal role in gadoxetic acid-enhanced MRI and recognition by the Western guidelines.
Golfieri R; Garzillo G; Ascanio S; Renzulli M
Dig Dis; 2014; 32(6):696-704. PubMed ID: 25376286
[TBL] [Abstract][Full Text] [Related]
9. Outcome of hypovascular hepatic nodules with positive uptake of gadoxetic acid in patients with cirrhosis.
Sano K; Ichikawa T; Motosugi U; Ichikawa S; Morisaka H; Enomoto N; Matsuda M; Fujii H
Eur Radiol; 2017 Feb; 27(2):518-525. PubMed ID: 27255397
[TBL] [Abstract][Full Text] [Related]
10. Progression of Hepatic Hypovascular Nodules with Hypointensity in the Hepatobiliary Phase of Gd-EOB-DTPA-enhanced MRI in Hepatocellular Carcinoma Cases.
Saitoh T; Sato S; Yazaki T; Tobita H; Miyake T; Ishihara S; Katsube T; Kitagaki H; Kinoshita Y
Intern Med; 2018 Jan; 57(2):165-171. PubMed ID: 29033416
[TBL] [Abstract][Full Text] [Related]
11. Was Hypervascular Hepatocellular Carcinoma Visible on Previous Gadoxetic Acid-Enhanced Magnetic Resonance Images?
Ichikawa S; Ichikawa T; Motosugi U; Sano K; Morisaka H; Enomoto N; Matsuda M; Fujii H
Liver Cancer; 2015 Sep; 4(3):154-62. PubMed ID: 26674263
[TBL] [Abstract][Full Text] [Related]
12. Significance of hypovascular lesions on dynamic computed tomography and/or gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging in patients with hepatocellular carcinoma.
Gyoda Y; Imamura H; Ichida H; Yoshimoto J; Ishizaki Y; Kuwatsuru R; Kawasaki S
J Gastroenterol Hepatol; 2019 Jul; 34(7):1242-1248. PubMed ID: 30345571
[TBL] [Abstract][Full Text] [Related]
13. Gadoxetic acid-enhanced magnetic resonance imaging can predict the pathologic stage of solitary hepatocellular carcinoma.
Chou YC; Lao IH; Hsieh PL; Su YY; Mak CW; Sun DP; Sheu MJ; Kuo HT; Chen TJ; Ho CH; Kuo YT
World J Gastroenterol; 2019 Jun; 25(21):2636-2649. PubMed ID: 31210715
[TBL] [Abstract][Full Text] [Related]
14. Kupffer phase image of Sonazoid-enhanced US is useful in predicting a hypervascularization of non-hypervascular hypointense hepatic lesions detected on Gd-EOB-DTPA-enhanced MRI: a multicenter retrospective study.
Inoue T; Hyodo T; Korenaga K; Murakami T; Imai Y; Higaki A; Suda T; Takano T; Miyoshi K; Koda M; Tanaka H; Iijima H; Ochi H; Hirooka M; Numata K; Kudo M
J Gastroenterol; 2016 Feb; 51(2):144-52. PubMed ID: 26373860
[TBL] [Abstract][Full Text] [Related]
15. Non-hypervascular hypointense nodules detected by Gd-EOB-DTPA-enhanced MRI are a risk factor for recurrence of HCC after hepatectomy.
Toyoda H; Kumada T; Tada T; Niinomi T; Ito T; Sone Y; Kaneoka Y; Maeda A
J Hepatol; 2013 Jun; 58(6):1174-80. PubMed ID: 23376360
[TBL] [Abstract][Full Text] [Related]
16. Intrahepatic distant recurrence after radiofrequency ablation for hepatocellular carcinoma: precursor nodules on pre-procedural gadoxetic acid-enhanced liver magnetic resonance imaging.
Song KD; Rhim H; Lee MW; Kim YS; Kang TW
Acta Radiol; 2017 Jul; 58(7):778-785. PubMed ID: 27903759
[TBL] [Abstract][Full Text] [Related]
17. Newly developed hypervascular hepatocellular carcinoma during follow-up periods in patients with chronic liver disease: observation in serial gadoxetic acid-enhanced MRI.
Yamamoto A; Ito K; Tamada T; Higaki A; Kanki A; Sato T; Tanimoto D
AJR Am J Roentgenol; 2013 Jun; 200(6):1254-60. PubMed ID: 23701061
[TBL] [Abstract][Full Text] [Related]
18. Superparamagnetic iron oxide-enhanced magnetic resonance imaging is useful in predicting malignant potential of vascular transformation of hypointense hypovascular nodules on gadoxetic acid-enhanced magnetic resonance imaging.
Tanaka Y; Nakazawa T; Inoue T; Yamane K; Kubota K; Uojima H; Takada J; Okuwaki Y; Hidaka H; Shibuya A; Kokubu S; Matsunaga K; Koizumi W
Hepatol Res; 2017 Oct; 47(11):1118-1126. PubMed ID: 27943555
[TBL] [Abstract][Full Text] [Related]
19. Non-hypervascular hepatobiliary phase hypointense nodules on gadoxetic acid-enhanced MRI: risk of HCC recurrence after radiofrequency ablation.
Lee DH; Lee JM; Lee JY; Kim SH; Kim JH; Yoon JH; Kim YJ; Lee JH; Yu SJ; Han JK; Choi BI
J Hepatol; 2015 May; 62(5):1122-30. PubMed ID: 25529623
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of combining gadolinium-ethoxybenzyl-diethylenetriamine pentaacetic acid-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for diagnosing the macroscopic classification of small hepatocellular carcinoma.
Kobayashi T; Aikata H; Hatooka M; Morio K; Morio R; Kan H; Fujino H; Fukuhara T; Masaki K; Ohno A; Naeshiro N; Nakahara T; Honda Y; Murakami E; Kawaoka T; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Hyogo H; Takahashi S; Chayama K
Eur Radiol; 2015 Nov; 25(11):3272-81. PubMed ID: 26037713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
